Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Old and New Biological Therapies for Psoriasis.

Rønholt K, Iversen L.

Int J Mol Sci. 2017 Nov 1;18(11). pii: E2297. doi: 10.3390/ijms18112297. Review.

2.

The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.

Mihailovic PM, Lio WM, Yano J, Zhao X, Zhou J, Chyu KY, Shah PK, Cercek B, Dimayuga PC.

PLoS One. 2017 Nov 1;12(11):e0187432. doi: 10.1371/journal.pone.0187432. eCollection 2017.

3.
4.

IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis.

Mehta NN, Teague HL, Swindell WR, Baumer Y, Ward NL, Xing X, Baugous B, Johnston A, Joshi AA, Silverman J, Barnes DH, Wolterink L, Nair RP, Stuart PE, Playford M, Voorhees JJ, Sarkar MK, Elder JT, Gallagher K, Ganesh SK, Gudjonsson JE.

Sci Rep. 2017 Oct 23;7(1):13831. doi: 10.1038/s41598-017-14365-1.

5.

Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?

Kaur S, Kingo K, Zilmer M.

Mediators Inflamm. 2017;2017:7279818. doi: 10.1155/2017/7279818. Epub 2017 Aug 29. Review.

6.

Assessment of subclinical cardiac damage in chronic plaque psoriasis patients: a case control study.

Ozden HK, Polat M, Ozturk S, Bugdayci G.

Arch Med Sci Atheroscler Dis. 2016 Dec 6;1(1):e126-e132. doi: 10.5114/amsad.2016.64165. eCollection 2016.

7.

Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital Study.

Singh S, Dogra S, Shafiq N, Bhansali A, Malhotra S.

Int J Appl Basic Med Res. 2017 Jul-Sep;7(3):169-175. doi: 10.4103/ijabmr.IJABMR_330_16.

8.

Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis.

Arbiser JL, Nowak R, Michaels K, Skabytska Y, Biedermann T, Lewis MJ, Bonner MY, Rao S, Gilbert LC, Yusuf N, Karlsson I, Fritz Y, Ward NL.

Sci Rep. 2017 Sep 11;7(1):11198. doi: 10.1038/s41598-017-10580-y.

9.

Unraveling Vascular Inflammation: From Immunology to Imaging.

Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, Swirski FK, Nestle F, Gelfand JM, Kaplan MJ, Grinspoon S, Ridker PM, Newby DE, Tawakol A, Fayad ZA, Mehta NN.

J Am Coll Cardiol. 2017 Sep 12;70(11):1403-1412. doi: 10.1016/j.jacc.2017.07.750. Review.

PMID:
28882238
10.

Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: a Nationwide Population-based Study.

Rhee TM, Lee JH, Choi EK, Han KD, Lee H, Park CS, Hwang D, Lee SR, Lim WH, Kang SH, Cha MJ, Cho Y, Oh IY, Oh S.

Sci Rep. 2017 Aug 30;7(1):9973. doi: 10.1038/s41598-017-10556-y.

11.

The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.

Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, Rodante J, Lerman JB, Ahlman MA, Gelfand JM, Mehta NN.

J Am Acad Dermatol. 2017 Oct;77(4):650-656.e3. doi: 10.1016/j.jaad.2017.06.028. Epub 2017 Aug 18.

PMID:
28826925
12.

Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry.

Menter A, Thaçi D, Wu JJ, Abramovits W, Kerdel F, Arikan D, Guo D, Ganguli A, Bereswill M, Camez A, Valdecantos WC.

Dermatol Ther (Heidelb). 2017 Sep;7(3):365-381. doi: 10.1007/s13555-017-0198-x. Epub 2017 Aug 16.

13.

Homocysteine: A Potential Common Route for Cardiovascular Risk and DNA Methylation in Psoriasis.

Wang WM, Jin HZ.

Chin Med J (Engl). 2017 Aug 20;130(16):1980-1986. doi: 10.4103/0366-6999.211895. Review.

14.

An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies.

Singh S, Young P, Armstrong AW.

PLoS One. 2017 Jul 18;12(7):e0181039. doi: 10.1371/journal.pone.0181039. eCollection 2017.

15.
16.

Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.

Furue M, Tsuji G, Chiba T, Kadono T.

Intern Med. 2017;56(13):1613-1619. doi: 10.2169/internalmedicine.56.8209. Epub 2017 Jul 1.

17.

The global state of psoriasis disease epidemiology: a workshop report.

Griffiths CEM, van der Walt JM, Ashcroft DM, Flohr C, Naldi L, Nijsten T, Augustin M.

Br J Dermatol. 2017 Jul;177(1):e4-e7. doi: 10.1111/bjd.15610. Epub 2017 May 28.

18.

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.

Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH.

Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z.

19.

Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort study.

Kim ES, Han K, Kim MK, Park YM, Baek KH, Moon SD, Han JH, Song KH, Kwon HS.

Sci Rep. 2017 May 16;7(1):1989. doi: 10.1038/s41598-017-01983-y.

Supplemental Content

Support Center